93% of Manufacturers Have MES, But Only 23% Have Fully Integrated It, New Rockwell Automation Report Finds
Press Release

93% of Manufacturers Have MES, But Only 23% Have Fully Integrated It, New Rockwell Automation Report Finds

Manufacturers are moving from MES deployment to enterprise-wide performance, but most are struggling to scale MILWAUKEE, July 14, 2026 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and digital transformation, today released "Scaling MES Across the Enterprise," an industry insights report based on input from 1,560 manufacturing and industrial […]

Read More
FranklinWH Energy Storage Systems Selected for Two New Texas Virtual Power Plant Programs
Press Release

FranklinWH Energy Storage Systems Selected for Two New Texas Virtual Power Plant Programs

Austin Energy and Entergy Texas select the FranklinWH System, a residential energy management and storage solution, for new demand response programs that reward homeowners for supporting grid reliability SAN JOSE, Calif., July 14, 2026 /PRNewswire/ — FranklinWH Energy Storage Inc. announced today that the FranklinWH System has been selected to participate in two new Texas utility […]

Read More
Global Semiconductor Equipment Sales Forecast to Reach a Record 9 Billion in 2028, SEMI Reports
Press Release

Global Semiconductor Equipment Sales Forecast to Reach a Record $229 Billion in 2028, SEMI Reports

AI-fueled Investment in Leading-edge Logic, Advanced Memory, Test and Packaging Drives Five-Year Growth Surge in Semiconductor Equipment MILPITAS, Calif., July 14, 2026 /PRNewswire/ — Global sales of total semiconductor manufacturing equipment by original equipment manufacturers (OEMs) are forecast to reach a record high of $165.9 billion in 2026, increasing 23.2% year-on-year, SEMI announced today in […]

Read More
Bizcap US launches, bringing fast, flexible funding to SMBs
Press Release

Bizcap US launches, bringing fast, flexible funding to SMBs

MIAMI, July 14, 2026 /PRNewswire/ — Global non-bank funder Bizcap has officially launched in the US, expanding its international footprint and bringing its proven funding model to one of the world’s largest small business markets. Albert Gahfi, Global Co-CEO of Bizcap Already operating across Australia, the UK, New Zealand, Singapore, Europe and Canada, Bizcap has […]

Read More
Standard Chartered Supports GBA Summit Officiated by HKSAR Chief Executive
Press Release

Standard Chartered Supports GBA Summit Officiated by HKSAR Chief Executive

Calls on SMEs to Accelerate Global Expansion and Seize New Cross-border Growth Opportunities HONG KONG, July 14, 2026 /PRNewswire/ — The GBA Global Business Expansion Summit, fully sponsored by Standard Chartered Bank (Hong Kong) Limited and organized by Television Broadcasts Limited (TVB), grandly opened in Hong Kong today. This year’s summit focuses on helping small and […]

Read More
NYSE Content Update: Madrona Highlights Private Companies Building AI Apps
Press Release

NYSE Content Update: Madrona Highlights Private Companies Building AI Apps

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 14, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.  Genspark previews Genspark.AI Workspace 6.0 Ashley Mastronardi delivers the pre-market […]

Read More
HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction
Press Release

HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction

BGE-102, a potent, structurally novel, orally available, brain-penetrant small molecule NLRP3 inhibitor developed from a hit identified via HitGen’s DEL technology platform, has advanced into a Phase 2 proof-of-concept trial for cardiovascular risk reduction. The QUELL-CV trial is designed to inform optimal dose selection in Phase 3 and BGE-102’s path forward in cardiovascular disease. Topline […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.